Evidence map›Paper›PMID 31480499›Full record

ArticleInsects2019

A Neonicotinoid Insecticide at a Rate Found in Nectar Reduces Longevity but Not Oogenesis in Monarch Butterflies,

David G James

Open access · goldAbstract read
In one paragraph

Article in Insects, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A butterfly flaps its wings: Extinction of biological experience and the origins of allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2020
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David G JamesDepartment of Entomology, Irrigated Agriculture Research and Extension Center, Washington State University, 24106 North Bunn Road, Prosser, WA 99350, USA. david_james@wsu.edu.ORCID 0000-0002-0494-6392
Washington State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The monarch butterfly in North America has suffered a serious population decline since the mid-1990s. The introduction and widespread use of neonicotinoid insecticides during the same time period has been suggested as a potential driver of this decline but no studies have looked at the impact of these insecticides on adult monarchs. A brief laboratory study assessed the impact of Imidacloprid, the most commonly used neonicotinoid, on western monarch butterfly longevity and oogenesis. Imidacloprid at 23.5 ppb, a field-realistic rate reported from wild nectar and pollen, was fed ad libitum to newly-eclosed monarchs in a sugar-based diet for 22 days. Treated monarchs showed reduced longevity, suffering 78.8% mortality by day 22, compared to 20% in untreated monarchs. Prior to death, butterflies exhibited signs of poisoning including uncoordinated flapping of wings and uncontrolled vibrating of wings and body. Imidacloprid did not reduce egg production. Shortened adult longevity has serious consequences for monarch population development, migration and overwintering. The potential widespread impact of imidacloprid-contaminated crop and wild flower nectar, may be a significant driver of monarch population decline. More research on the impact of neonicotinoid insecticides on the monarch and other butterflies should be viewed as a serious priority.

Indexed as

adult monarch butterflyimidaclopridmonarch butterfly declineneonicotinoidssurvival

Identifiers

PMID31480499
PMCPMC6780620
OpenAlexW2970428614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.